Culture

Investigating the carbon intensity of ferries

Climate change mitigation requires curbing emissions from all sectors, including shipping. The European Union has set ambitious targets to achieve this goal. The European regulation number 757 on Monitoring, Reporting, and Verification of CO2 emissions (EU-MRV) contributes to it by collecting CO2 emission data from all vessels above 5,000 GT calling at ports within the European Economic Area.
In this area, ferries represent just 3% of all vessels. However, in 2018 they accounted for 10% of CO2 emissions from all ships in the EU-MRV. Why carbon footprint of ferries is so high? Is it related to sea or navigational conditions? Or perhaps to any characteristics of the vessels?

A CMCC study presented last June during the 21st IEEE International Conference on Mobile Data Management and realized in the framework of GUTTA project’s activities, explores this issue while providing new insights and perspective.
The analysis, led by Gianandrea Mannarini, senior scientist at the CMCC Foundation, explores various energy efficiency indicators. Results reveal some clustering in the vessel population and the key factors are year of build, vessel length, service speed, and fuel type. Georeferencing data provide additional information on the continental patterns of the Ro-Pax emissions.

About the half of the total ferry emissions stem from the Mediterranean; this largely reflects a greater number of ships operating in this sea. More in detail, the study highlights a weak correlation between CO2 emission per service hours and the mean annual sea state (significant height of waves where the ferry operates); this correlation is slightly higher just for smaller ferries (i.e., length below 120 meters). Researchers also assess which factors influence ferry carbon intensity, defined as CO2 emissions per transport work, highlighting a great variability spanning five orders of magnitude, while the ferry size varies by less than two.
“This variability is influenced by many factors” Gianandrea Mannarini explains, “such as ferry size, propulsion features, age and other characteristics of the Ro-Pax vessels, such as number of vehicles carries, number of cabins available and other passenger services. However, we will have to use data from multiple years for better analysing how ferries performed with respect to emissions”.

In certain ways, energy efficiency reflects the ship’s age and the tendency to build bigger and bigger ships during the last decades. “The data”, Mannarini adds, “indicate that some of the most carbon intensive vessels were built during the past 20 years. More and better time-resolved emission data from the vessels, possibly at individual voyage level, would enable a better assessment, which is the first step for informing International policies and regulations aimed at reducing both carbon intensity and absolute emissions.”

For further information, read the integral version of study:
EU-MRV: an analysis of 2018’s Ro-Pax CO2 data
G. Mannarini, L. Carelli, and A. Salhi. EU-MRV: an analysis of 2018’s Ro-Pax CO2 data. In 21st IEEE International Conference on Mobile Data Management (MDM), pages 287–292. IEEE, 2020. DOI: 10.1109/MDM48529.2020.00065

The original MRV data used for this work can be downloaded from EMSA

More information on GUTTA aims and activities here.

DOI

10.1109/MDM48529.2020.00065

Credit: 
CMCC Foundation - Euro-Mediterranean Center on Climate Change

Optogenetic method can reveal how gut microbes affect longevity

Research has shown that gut microbes can influence several aspects of the host's life, including aging. Given the complexity and heterogeneity of the human gut environment, elucidating how a specific microbial species contributes to longevity has been challenging. To explore the influence of bacterial products on the aging process, researchers at Baylor College of Medicine and Rice University developed a method that uses light to directly control gene expression and metabolite production from bacteria residing in the gut of the laboratory worm Caenorhabditis elegans.

They report in the journal eLife that green-light-induced production of colanic acid by resident E. coli bacteria protected gut cells against stress-induced cellular damage and extended the worm's lifespan. The researchers indicate that this method can be applied to study other bacteria and propose that it also might provide in the future a new way to fine-tune bacterial metabolism in the host gut to deliver health benefits with minimal side effects.

"We used optogenetics, a method that combines light and genetically engineered light-sensitive proteins to regulate molecular events in a targeted manner in living cells or organisms," said co-corresponding author Dr. Meng Wang, Robert C. Fyfe Endowed Chair on Aging and professor of molecular and human genetics and the Huffington Center on Aging at Baylor.

In the current work, the team engineered E. coli to produce the pro-longevity compound colanic acid in response to green light and switch off its production in red light. They discovered that shining the green light on the transparent worms carrying the modified E. coli induced the bacteria to produce colanic acid, which protected the worm's gut cells against stress-induced mitochondrial fragmentation. Mitochondria have been increasingly recognized as important players in the aging process.

"When exposed to green light, worms carrying this E. coli strain also lived longer. The stronger the light, the longer the lifespan," said Wang, an investigator at Howard Hughes Medical Institute and member of Baylor's Dan L Duncan Comprehensive Cancer Center. "Optogenetics offers a direct way to manipulate gut bacterial metabolism in a temporally, quantitatively and spatially controlled manner and enhance host fitness."

"For instance, this work suggests that we could engineer gut bacteria to secrete more colanic acid to combat age-related health issues," said co-corresponding author Dr. Jeffrey Tabor, associate professor of bioengineering and biosciences at Rice University. "Researchers also can use this optogenetic method to unravel other mechanisms by which microbial metabolism drives host physiological changes and influences health and disease."

Credit: 
Baylor College of Medicine

'No such thing as a little bit of pain:' More cancer patients could benefit from rehabilitation

image: Rehabilitation can preserve cancer patients' quality of life as they undergo and recover from treatment. But according to Nicole Stout--a researcher with the WVU School of Public Health and Cancer Institute--they're underutilized services. To support the World Health Organization's effort to fix that problem, Stout reviewed cancer-treatment guidelines from around the world and identified the rehabilitation services they recommended. The recommendations she gathered will help the WHO develop a new, unified rehabilitation toolkit.

Image: 
Aira Burkhart/WVU

Cancer treatment isn't just a matter of shrinking or removing a tumor. It also involves preserving or improving the patient's quality of life. Rehabilitation services--such as behavioral therapies to alleviate pain and exercise to reduce fatigue--are a valuable way to do that. But they often aren't included in cancer patients' plans of care.

"Rehabilitation has been an underdog in cancer treatment," said Nicole Stout, a research assistant professor with the West Virginia University School of Public Health and WVU Cancer Institute. "It hasn't been top of mind."

In a new systematic review, Stout and her colleagues identified the rehabilitation recommendations included in cancer-treatment guidelines from around the world. The guidelines recommended rehabilitation for a variety of cancer types and consequences of cancer treatment. But the researchers discovered a disconnect between what the guidelines suggested and what many doctors do.

Their findings appear in CA: A Cancer Journal for Clinicians.

"When we look at the evidence, somewhere between 2% and 9% of patients who have demonstrated functional impairments actually get referred to rehab," Stout said. "It's very underutilized."

She said there are many reasons for this. Counterintuitively, one of the most significant reasons is how good we've gotten at diagnosing and treating cancer.

"Quite frankly, most people in the past didn't survive a cancer diagnosis," she said. "In the late 1970s, only about 30% to 40% of people who had cancer would live beyond five years. Today that number is over 70%. And for some of the most common cancers--like breast and prostate--90% of those folks will live beyond five years and go on to live their full lifespan. It's not good enough anymore for us to just say, 'Well, look: you're just going to have to live with pain and fatigue.' And the evidence for rehabilitation has just grown so significantly to show us that we can really help those people."

Treating the whole person

As a medical domain, rehabilitation focuses on functionality--or, someone's ability to think, speak, move and carry out the countless other activities that make up daily life. It encompasses a wide range of treatments, from music therapy to transcutaneous electrical nerve stimulation.

Although rehabilitation is often associated with learning to walk again after a stroke or a joint-replacement surgery, it can also be crucial to preventing problems before they arise.

"There's no such thing as a little bit of pain or a little bit of swelling or a little bit of limited movement in your joint," Stout said. "Today it might be a little bit, but in three weeks or three years, those things can escalate."

Where are all the patients?

To be included in Stout's review, guidelines had to meet several criteria. For example, they had to be published between Jan. 1, 2009 and June 1, 2019. They had to deal specifically with cancer patients. And they had to be endorsed by a professional oncology or rehabilitation organization.

Sixty-nine guidelines met all of the criteria. Of those, 37 recommended that cancer patients be referred to rehabilitation services but gave no additional guidance. The other 32 suggested specific rehabilitation assessments and interventions.

"For us on the rehabilitation end of things, we're always asking, 'Gosh, why are these doctors not sending more of their patients to rehab?'" Stout said. "Then we do this systematic review, and we see 69 guidelines, and we're like, 'There are all these guidelines. Why aren't we seeing more patients referred? How do we implement the guidelines into practice?"

'Greatest hits album' of rehabilitation recommendations

To make these guidelines more effective, the World Health Organization launched its Rehabilitation 2030 initiative, which Stout's review supports.

As part of the initiative, the WHO is identifying rehabilitation-specific recommendations in a variety of medical disciplines, including oncology. The WHO will then compile the "greatest hits" of those guidelines into one toolkit, Stout said.

"This is where the greatest hits album that the WHO puts together will really be impactful because it will synthesize all of these findings into one place and break it out by disease type or type of impairment," she said.

Providing a single, trustworthy source of guidelines may improve the likelihood that physicians will refer their patients to rehabilitation services.

In the meantime, Stout recommends that patients be their own advocate.

"I encourage patients to not just ask, 'Do you think we should do something about this swelling that I'm having?'" she said. "They need to tell their physician, 'I'm having swelling. I need a referral to see a rehabilitation specialist.' And you know what? The doctor and the nurse, they'll do it."

Credit: 
West Virginia University

ACE2 protein protects against severe COVID-19: Study

image: Gavin Oudit, professor of medicine at the University of Alberta and Canada Research Chair in Heart Failure, helped lead research that found female COVID-19 patients face less severe disease complications and a lower risk of dying than male patients thanks to hormones and chromosomes that contribute to a stronger immune response.

Image: 
University of Alberta

Female COVID-19 patients face less severe disease complications and a lower risk of dying than male patients thanks to hormones and chromosomes that contribute to a stronger immune response, according to new research from a University of Alberta-led team.

"The highlight of our study is how the sex differences in COVID-19 are linked to ACE2," said senior author Gavin Oudit, professor of medicine in the Faculty of Medicine & Dentistry, Canada Research Chair in Heart Failure and director of the Heart Function Clinic at the Mazankowski Alberta Heart Institute.

ACE2 is the enzyme that acts as the receptor allowing SARS-CoV-2 to enter the body, but it is also key in protecting against cardiovascular, lung and kidney diseases.

"Because of their chromosomes, women have two copies of the ACE2 gene and men have only one copy," Oudit said. "This does not seem to make women more susceptible to COVID-19 infection, but it does protect them from the complications associated with the virus."

Oudit explained that ACE2 is an X chromosome-linked gene. To avoid duplication, one X chromosome tends to be inactivated, but due to its location ACE2 escapes inactivation, meaning women have twice as many active genetic instructions to make ACE2.

Another gene that is twice as strong in women due to this X-inactivation escape is called Toll-like receptor seven, a key part of the innate immune system.

"The stronger presence of Toll-like receptor seven in women explains why women's immune systems are stronger than men's and can tolerate virus infection better, including the common cold," Oudit said. "The man-cold phenomenon is real."

In the study, the researchers report that men face more severe illness and poorer outcomes around the world, including in Alberta. They note that women likely face more exposure to SARS-CoV-2 than men--for example, 70 per cent of health-care workers are female--but this is not reflected in their outcomes.

"Due to gender issues, women face more risk, so it's reassuring to know that their outcomes are not any worse; in fact they are clearly better than men's," Oudit said.

Research is underway to understand how manipulating ACE2 levels might help COVID-19 patients, to prevent infection by blocking the enzyme or to protect the cardiovascular system, lungs and kidneys by enhancing it.

"We need to look at the factors that are responsible for better outcomes for everyone, taking sex differences into consideration when we test new therapies and provide COVID-19 care," said Oudit.

Credit: 
University of Alberta Faculty of Medicine & Dentistry

New toolkit aims to improve quality of thrombosis data in COVID-19 trials

The ASH Research Collaborative (ASH RC) and the International Society of Haemostasis and Thrombosis (ISTH), two organizations with multidisciplinary expertise in blood clotting and bleeding disorders, have developed a toolkit to help clinical researchers from across medical disciplines design clinical trials that further the understanding of blood clotting events associated with COVID-19.

The new Toolkit for the Collection of Thrombosis-Related Data Elements in COVID-19 Clinical Studies, published today in Blood Advances, defines a series of endpoints - events or outcomes that are measured in a clinical study - that should be included in study design to collect and analyze important, relevant, and standardized data on dangerous blood clots that form in the veins or arteries of patients with COVID-19. The goal of this initiative is to maximize high-quality collection of COVID-19-associated clotting and bleeding events across diverse medical fields, such as internal medicine, infectious disease, pulmonology, and emergency or critical care medicine, which may capture these events as secondary endpoints or outcomes.

"Researchers across various disciplines are conducting clinical trials in COVID-19, and because they are not attuned to collecting these data we are seeing ranges of incidences," said 2020 ASH RC President Stephanie Lee, MD, MPH of the Fred Hutchinson Cancer Research Institute and President of the American Society of Hematology (ASH). "ASH RC and ISTH developed this toolkit to harmonize data collection and help all clinical researchers speak the same language. Standardizing how thrombosis is defined and measured across all COVID-19 trials will give us a more complete picture of the magnitude of risk - who is experiencing blood clots, what predisposes them to clotting - which could lead to the development of more targeted interventions and treatments."

While abnormal blood clotting is an established complication of COVID-19, particularly in hospitalized patients, the precise incidence, risk factors, and natural history of these events remains uncertain due to inconsistencies in how studies are being designed and conducted. As a result, it has been challenging to apply clinical insights from studies into practice. To address this issue, the ASH RC and ISTH established uniform definitions of thrombosis-related outcomes for incorporation into COVID-19 clinical trials addressing a diverse range of interventions.

"The ISTH is pleased to collaborate with ASH on this important initiative, and we encourage investigators to use this toolkit, which will standardize data collection and allow for better comparison of findings across trials," said Jeffrey Weitz, MD, ISTH President. "The collaboration utilized the recently approved ISTH Common Data Elements for venous thromboembolism, supporting the ISTH CDE project's goal of establishing a consistent vocabulary for clinical research."

The toolkit includes a customizable range of options for maximal flexibility, from a limited set of essential variables to a comprehensive set of clinical and biological variables, including variable definitions, permissible values, and measurement tools and units. Depending on the individual study objectives, design, and available resources, investigators can select from three levels of detail in seven domains: venous thromboembolism, myocardial infarction, stroke/transient ischemic attack, peripheral artery thrombosis, bleeding, laboratory investigations, and antithrombotic therapy. This turnkey solution is designed to create efficiency in study design and implementation by providing a pre-established, standardized set of variables vetted by individuals with expertise in thrombosis and hemostasis and clinical trial development.

Credit: 
American Society of Hematology

Nurse practitioners bring big savings to long-term care facilities in Quebec

Countries worldwide face challenges meeting the growing needs for long-term care services because of high costs. A study led by researchers from McGill University and Université du Québec en Outaouais shows that introducing nurse practitioners can significantly reduce costs and improve patient safety.

According to the study, published in Nursing Outlook, cost savings for on-site nurse practitioner care for adverse events were between 1.9 and 3.2 million dollars across the six sites, including the reduction of nursing administration time for medications. Once introduced, nurse practitioners managed patients' medications and adverse events including falls, pressure ulcers, and short-term transfers to the hospital.

"Internationally, most studies have focused on quality and safety in long-term care. Little is known about the economic impacts of the care provided to patients by nurse practitioners, particularly in Quebec, where the roles are still new," says co-author Kelley Kilpatrick, an associate professor at the Ingram School of Nursing at McGill University. The study is the first to look at cost savings resulting from their work in decreasing adverse events.

Pilot project: a success

Nurse practitioner roles were introduced in the United States and some provinces in Canada in the 1960s. However, their history is fairly recent in Quebec, due to differences in regulatory laws in the province. Up until early 2019, the diagnosis of a health condition needed to be made by a physician. Those laws are now under revision.

In 2015, Quebec implemented nurse practitioner roles in six long-term care facilities as a pilot project. Nurse practitioners are trained at the graduate level with a specialty certificate in primary care. Working in partnership with physicians and an interprofessional team, they assess residents' condition, adjust medications, order and interpret diagnostic tests, and provide ongoing chronic illness care.

"Put together, our research shows that close collaboration between nurse practitioners, physicians, and the rest of the healthcare team, helps all team members play their role more effectively," says Kilpatrick, who is also a researcher at the Centre de recherche de l'Hôpital Maisonneuve-Rosemont, part of the CIUSSS de l'Est-de-l'Île-de-Montréal.

The researchers note that sixteen percent of the world's population, 1.5 billion people, will be 65 years or older by 2050. Because countries must respond to increasing needs of this population, innovative approaches are needed to improve long-term care services.

"Nurse practitioners are part of the solution to meet the growing needs for quality long-term care. They play a key role in ensuring high quality care for residents in long-term care and reduce costs," says co-author Eric Tchouaket, a professor at the Department of Nursing at Université du Québec en Outaouais.

Credit: 
McGill University

Researchers discover brain pattern that could improve mental health disorder diagnosis

A pattern in how the brain breaks down tryptophan, a common amino acid consumed through food, was discovered by researchers at The University of Texas Health Science Center at Houston (UTHealth). The finding, which could help physicians more accurately diagnose and treat several major mental health disorders, was recently published in Molecular Psychiatry.

"Tryptophan can be metabolized to either a route where serotonin is produced, or to the kynurenine pathway," said Brisa Fernandes, MD, MSc, PhD, a postdoctoral research fellow with the Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences at McGovern Medical School at UTHealth and co-senior author of the paper. "The research shows that people with mood disorders and schizophrenia not only have decreased levels of tryptophan overall, but the tryptophan they do have is being broken down more often in the kynurenine pathway, shifting away from the production of serotonin, the chemical made from tryptophan that is thought to regulate anxiety and improve mood."

Researchers conducted a systematic review of more than 100 peer-reviewed studies assessing kynurenine metabolites, which are the tryptophan amino acids being broken down in the kynurenine pathway, in people with major depressive disorder, schizophrenia, or bipolar disorder, compared to healthy controls. Within those studies, which included more than 10,000 study participants, they examined the difference in metabolite concentrations between each group.

"We chose these disorders because they share several biological pathways, meaning the same root causes and pathophysiology. We tried to find biomarkers that are common among these disorders, but most importantly, biomarkers that distinguish them. This is essential to help clinicians guide treatment and implement personalized medicine in psychiatry - not the 'one-size-fits-all' approach that is so prevalent today," Fernandes said.

As the tryptophan breaks down in the brain, it can use the kynurenine pathway to turn into quinolinic acid, which is considered neurotoxic, or kynurenic acid, which is considered neuroprotective.

Researchers identified several patterns that occur as tryptophan breaks down that collectively suggest there is a shift from serotonin production to the kynurenine pathway, which could lead to increased neurotoxicity from the quinolinic acid.

"This can help us to develop new tests for diagnosing these disorders and, more importantly, of discovering and selecting new treatments for people with mood disorders and schizophrenia that will be more personalized," Fernandes said.

"The major challenge that we have in psychiatry is having biomarkers to differentiate one diagnostic from the other, as our diagnoses are 100% clinical. This is the type of research we need to identify those biomarkers, and the next step for us now is to see if we can validate these findings in our patients," said João de Quevedo, MD, PhD, professor of psychiatry and behavioral sciences and co-author of the study.

"This is important research that hopefully will lead to a better understanding of mechanisms involved in major mental illnesses, as well as a higher level of personalization in treatments so we can best match patients to a treatment plan we know will help them," said Jair Soares, MD, PhD, the Pat R. Rutherford, Jr. Chair in Psychiatry in the Faillace Department of Psychiatry and Behavioral Sciences and co-senior author. Soares and de Quevedo see patients at UT Physicians, the clinical practice of McGovern Medical School.

Credit: 
University of Texas Health Science Center at Houston

Financial woes grow worse during pandemic for American families

The economic challenges caused by the coronavirus pandemic have grown worse since the spring for many American families, with an increasing number reporting that they have trouble paying bills, according to a new RAND Corporation study.

Surveyed several times over the course of the pandemic, nearly 45% of study participants report that they had difficulty paying bills at some point since February and 13% reported it had been been very difficult to pay bills at some point during the period.

Preliminary results from another wave of the survey conducted in early December suggests that many people plan to spend less than usual on holiday gifts this year, which also could indicate continuing financial hardship.

"Despite some recent increases in employment and consumer spending, many American families continue to struggle financially," said Katherine G. Carman, the study's lead author and a senior economist at RAND, a nonprofit research organization. "The challenges are particularly severe among lower income workers, and among Black and Hispanic households."

The survey was fielded using the RAND American Life Panel, a nationally representative internet panel, to assess the effects of the COVID-19 pandemic on individuals and households across a variety of topics.

The RAND study analyzes results from 1,277 people who were working during February 2020 and were asked them about their finances during May, June, August and September.

The number of Americans who reported troubles paying bills increased from 27% in May (7% reported that it was very difficult and 20% that it was somewhat difficult) to 32% in September (9% reported that it was very difficult and 23% that it was somewhat difficult).

Researchers found that people who report financial difficulties were more likely to turn to formal credit such as credit cards or payday loans, in addition to informal methods such as borrowing from friends or selling belongings. Over time, those who report financial difficulty became even more likely to turn to one of these strategies or to report that they could not cover expenses at all.

For example, among those reporting trouble paying bills, the number of people who reported using formal credit to meet obligations rose from 41% in May to 47% in September. Those reporting they could not pay their bills rose from 25% in May to 30% in September.

Only those who had experienced financial difficulties reported that they have asked or would ask for an extension in paying their rent or mortgage, both of which are easier under the terms of the CARES act.

People who reported using stimulus funds declined over time, likely because people had already spent the funds or because they had become less salient.

Researchers say the differences across racial groups was striking. In May, 20% of Non-Hispanic White respondents reported financial difficulties, compared with 42% of Non-Hispanic Black respondents and 47% of Hispanic respondents.

As in the overall sample, the share of Americans who reported financial difficulties at any point during the four waves of the study is about 15 percentage points higher than the share who experience difficulty in the first wave, for all three of the racial groups.

Unsurprisingly, financial difficulties were more common among lower income households. Among study participants who were working in February, more than 70% of low-income households (under $25,000 in annual income) reported financial difficulties at some point during the four waves of the survey.

Meanwhile, 47% of middle-income households (income between $25,000 and $125,000), and 20% of high-income households (income above $125,000) reported financial difficulties at some point from May to September.

Credit: 
RAND Corporation

Upcycling: new catalytic process turns plastic bags into adhesives

image: Using a catalyst based on ruthenium (gold ball, center), UC Berkeley chemists were able to add specific chemical groups -- in this case, OH (red) - to polyethylene polymer chains, creating an oxidized polyethylene (foreground) that adheres strongly to metal but retains the unique plastic properties of the polymer.

Image: 
UC Berkeley image by Liye Chen

While many cities and eight states have banned single-use plastics, bags and other polyethylene packaging still clog landfills and pollute rivers and oceans.

One major problem with recycling polyethylene, which makes up one-third of all plastic production worldwide, is economic: Recycled bags end up in low-value products, such as decks and construction material, providing little incentive to reuse the waste.

A new chemical process developed at the University of California, Berkeley, converts polyethylene plastic into a strong and more valuable adhesive and could change that calculus.

"The vision is that you would take a plastic bag that is of no value, and instead of throwing it away, where it ends up in a landfill, you would turn it into something of high value," said John Hartwig, the Henry Rapoport Chair in Organic Chemistry at UC Berkeley and leader of the research team. "You couldn't take all of this recycled plastic -- hundreds of billions of pounds of polyethylene are produced each year -- and turn it into a material with adhesive properties, but if you take some fraction of that and turn it into something that is of high value, that can change the economics of turning the rest of it into something that is of lower value."

For most plastics, recycling means chopping it up and forming it into generic products, in the process tossing out many of the properties painstakingly engineered into the original plastic, such as pliability and ease of processing. And while new methods of recycling can break down plastics into their chemical constituents for use as fuels or lubricants, these products, too, are low-value and can be environmentally questionable -- another fossil fuel to burn -- or have a short lifetime.

To make recycling more attractive, researchers and the plastics industry have been looking for ways to "upcycle" -- that is, convert recycled plastic into something more valuable and longer-lived.

The chemical process that Hartwig and his colleagues developed keeps many of the original properties of polyethylene, but adds a chemical group to the polymer that makes it stick to metal: something polyethylene normally does poorly. His team showed that the modified polyethylene can even be painted with water-based latex. Latex easily peels off standard low-density polyethylene, referred to as LDPE.

The paper describing this process will be published online Dec. 17 in the journal Chem and will appear in January's printed edition.

"We are able to enhance adhesion, while preserving all the other traits of polyethylene that the industry finds so useful," said co-author Phillip Messersmith, the Class of 1941 Professor in UC Berkeley's departments of bioengineering and materials science and engineering. "The processability, thermal stability and mechanical properties seem to be unharmed while enhancing adhesion. That is tricky to do. That is really where we have some exciting things to show."

While the process is not yet economical for industrial use, Hartwig believes that it can be improved and could be the starting point for adding other properties besides stickiness. The success also hints that other catalysts could work with other types of plastics, such as the polypropylene found in recycled plastic bottles, to produce higher-value products that are economically attractive.

Tweaking hydrocarbon chains

Hartwig specializes in designing new catalytic processes -- in this case, adding small chemical units to large hydrocarbon chains, or polymers, in very specific places -- to create "functionalized polymers" with new and useful properties. Such reactions are difficult, because a major selling point of plastics is that they are resistant to chemical reactions.

For this project, he wanted to see if he could add a hydroxyl group -- oxygen bound to hydrogen, or OH -- at a small fraction of the carbon-hydrogen bonds along the polyethylene chain.

"Polyethylene usually has between 2,000 and 10,000 carbons in a chain, with two hydrogens on each carbon -- really, it is an ocean of CH2 groups, called methylenes," he said. "We dipped into the literature to look for the most active catalyst we could find for functionalization of a methylene position."

The catalyst would have to work at high temperatures, since the solid recycled plastic has to be melted. Also, it would have to work in a solvent that is nonpolar, and thus able to mix with polyethylene, which is nonpolar. This is one reason it does not stick to metals, which are polar, or charged.

Hartwig and postdoctoral associate Liye Chen settled on a ruthenium-based catalyst (polyfluorinated ruthenium porphyrin) that satisfied these requirements and also could add OH groups to the polymer chain without the highly reactive hydroxyl breaking the polymer chain apart.

The reaction, surprisingly, produced a polyethylene compound that sticks tightly to aluminum metal, presumably by means of the OH molecules affixed along polyethylene's hydrocarbon chain. To better understand the adhesion, Chen teamed up with Katerina Malollari, a graduate student in Messersmith's lab, which focuses on biological tissues with adhesive properties -- in particular, a glue produced by mussels.

Chen and Malollari discovered that adding a relatively small percentage of alcohol to the polymer boosted adhesion 20 times.

"The catalysis introduced chemical changes to less than 10% of the polymer, yet enhanced dramatically its ability to adhere to other surfaces," Messersmith said.

Getting polyethylene to adhere to things -- including latex paint -- opens up many opportunities, he added. Artificial hip sockets and knee implants often integrate polyethylene with metal components and could be made to adhere better to metal. Functionalized polyethylene could be used to coat electrical wire, provide the glue that sticks other polymers together -- in milk cartons, for example -- or make more durable composites of plastic and metal, such as in toys.

"The utility here is being able to introduce these functional groups, which help solve many longstanding problems in polyethylene adhesion: adhesion of polyethylene to other polyethylene or to other polymers, as well as to metal," Messersmith said.

Hartwig foresees more opportunities for functionalization of complex polymers, including the most common plastic, polypropylene.

"We are one of the only groups anywhere that has been able to selectively introduce a functional group to long-chain hydrocarbon polymers," he said. "Other people can break the chains, and others can cyclize the chains, but to actually introduce a polar functional group into the chains is something that nobody else has been able to do."

Credit: 
University of California - Berkeley

Researcher boosts vegetable oil production in plant leaves

image: Jay Thelen is a professor of biochemistry at the University of Missouri.

Image: 
University of Missouri.

Since antiquity, cultures around the world have been extracting vegetable oil from plants to use as food and fuel. Some vegetable oils have important health benefits, including lowering cholesterol levels and decreasing the risk of cardiovascular disease.

But there's a problem: Vegetable oils are traditionally extracted from fruits or seeds, and the extraction process often leads to the rest of the plant being discarded in the process. Now, Jay Thelen, a professor of biochemistry at the University of Missouri, has found a way to boost the production of triacylglycerol -- the main component of vegetable oil -- in plant leaves, a technique that could allow producers to harvest oil from large, leafy plants that also have other uses. Sorghum, for example -- a global source of grain prized for its drought-resistant qualities -- could serve a dual role as a source of vegetable oil, creating a more efficient and valuable crop.

Thelen and Yajin Ye, a postdoctoral fellow in Thelen's lab at MU, used the gene editing tool CRISPR to "knock out" a family of genes they have found to be responsible for regulating fatty acid production in the leaves of Arabidopsis, a plant regularly used by researchers to study plant biochemistry. The results were recently published in the prestigious journal Nature Communications.

"We know that plants synthesize fatty acids when provided light," said Thelen, who has dual appointments in the College of Agriculture, Food and Natural Resources and the Bond Life Sciences Center. "This study taught us that there are three proteins that restrain this process in leaves, and that we can turn off their cognate genes using CRISPR. That frees up the plant to produce higher amounts of triacylglycerol in the leaves rather than just the seed."

Thelen said this method could lead to greater and cheaper production of vegetable oils, and the possibility of dual uses for leafy crops like sorghum and soybeans could place less of a burden on making a higher-oil seed. That burden often has undesirable consequences -- including a decrease in protein, which is the principal commodity in soybean seeds. His lab is now in the process of further testing the method on crops to confirm its viability.

A hunger for research

If anyone seemed prepared to make this discovery, it was Jay Thelen. Hailing from the small town of Seward, Nebraska, Thelen has been seriously pursuing science research since high school more than three decades ago, when he found himself in the classroom of Jim Landon, a nationally renowned science teacher with an unorthodox style.

"We got out of the classroom and did ecological experiments on nature reserves," Thelen said. "We went hiking, assisted with invasive species studies and even helped out on prehistoric digs. We uncovered mastodon bones. It was really impactful stuff."

Landon took Thelen under his wing, arranging for him to participate in university-caliber research at the University of Nebraska during the summer and -- once in a while -- on weekends during the school year. Landon, now in his seventies and enjoying retirement in the state of Washington, remembers his former student clearly.

"Jay was a great kid; very inquisitive," Landon said. "I remember when he was chosen to present his research at the 40th International Science and Engineering Fair in Pittsburgh in 1989. Only a handful of students from Nebraska, Kansas and Oklahoma were selected, and I can still see him standing up there and doing his presentation. In high school, when the athletes sometimes get all the glory, it was great to see Jay take the initiative to do research and even better to see that initiative rewarded."

Teacher and student have gone on to separate career paths, but they still talk once in a while, reflecting the impact each had on the other. Thelen credits Landon for sparking his fascination with science, while Landon speaks lavishly of how students like Thelen have fueled his passion for teaching throughout his career.

"It just amazes me what the kids I've taught have gone on to accomplish," Landon said. "For Jay's research to be published in a journal as prestigious as Nature Communications, it just makes me so proud."

Despite his success, Thelen has no plans to slow down when it comes to the research that drives his love of science.

"For me, understanding how plant metabolism is regulated is an itch that needs to be scratched," Thelen said. "Plants are the original 'green' factories for food, chemical feedstock and fuel production. Discovering new metabolic constraints and leveraging these findings to help us adapt to a warming planet -- that's something that motivates me, and there's still much more to be done."

Credit: 
University of Missouri-Columbia

UCI researchers create model to calculate COVID-19 health outcomes

Irvine, Calif., Dec. 17, 2020 --University of California, Irvine health sciences researchers have created a machine-learning model to predict the probability that a COVID-19 patient will need a ventilator or ICU care. The tool is free and available online for any healthcare organization to use.

"The goal is to give an earlier alert to clinicians to identify patients who may be vulnerable at the onset," said Daniel S. Chow, an assistant professor in residence in radiological sciences and first author of the study, published in PLOS ONE. The tool predicts whether a patient's condition will worsen within 72 hours.

Coupled with decision-making specific to the healthcare setting in which the tool is used, the model uses a patient's medical history to determine who can be sent home and who will need critical care. The study found that at UCI Health, the tool's predictions were accurate about 95 percent of the time.

"We might think about this tool in terms of predicting the number of ICU beds that we might need," said Alpesh N. Amin, the Thomas & Mary Cesario Chair of Medicine and a study author.

The researchers started collecting COVID-19 patient data at UCI Health in January 2020, allowing them to produce a prototype of the tool by March and begin this study shortly after.

The machine-learning model used UCI Health patient data to create an algorithm that uses pre-existing conditions - such as asthma, hypertension and obesity - hospital test results and demographic data to calculate the likelihood that a patient will need a ventilator or ICU care.

Though the study was based on UCI Health patients - who share a location and were primarily Asian-American, Latino and Caucasian - the researchers also tested the tool with 40 patients at Emory University in Atlanta to see whether it worked with a different patient population. It did.

While the calculator will predict the general severity score of COVID-19 patients at any hospital, clinicians must make decisions on how to proceed based on local practices and their own number of beds, number of patients, likely spread of the disease locally, etc. At UCI Health, the tool has guided patient care based on feedback from emergency, hospital medicine, critical care and infectious disease physicians.

"You have to talk to your specialists, your doctors; you have to assess how many beds you have available and come together as a group to figure out how you want to use the tool," said Peter Chang, the assistant professor in residence in radiological sciences who designed the machine-learning model.

The team plans to expand the tool to other institutions and use it for further research. In their next study, they aim to predict which patients are most likely to benefit from COVID-19 drug trials.

This study was a collaboration between the School of Medicine, the Sue and Bill Gross School of Nursing, the Program in Public Health and the Department of Computer Science.

Credit: 
University of California - Irvine

Taking greenhouse gas analysis on the road, er, rails

image: A UTA TRAX train on the University of Utah campus.

Image: 
University of Utah

Research-grade air quality sensors are costly--around $40,000. For cities trying to monitor their greenhouse gas emissions, the cost may limit the number of sensors they can install and the data they can collect.

Unless. . .

Since 2014, the University of Utah has maintained research-grade suites of air quality instruments installed on light rail trains that move throughout the Salt Lake Valley every day. These mobile sensors, researchers estimate in a new study, cover the same area as 30 stationary sensors, providing the Salt Lake Valley with a highly cost-effective way to monitor its greenhouse emissions and fill in gaps in emissions estimates. The study is published in Environmental Science & Technology.

"Pollutant levels in the atmosphere are going to be rapidly changing in the coming decade as clean energy technologies are deployed," says Logan Mitchell, research assistant professor of atmospheric sciences, and a co-author of the study. "Cost-effective atmospheric monitoring will help policymakers understand what policies lead to reductions in pollutant levels, where there needs to be more focus, and if there are environmental inequalities emerging as some areas reduce their emissions faster than other areas."

Taking the show on the road

The upwind atmospheric area sampled by four current stationary air quality monitors (left) compared with the area sampled by a train-based mobile sensor.

The story of mounting sensors on the trains of the Utah Transit Authority's TRAX system begins in 2009 with then-doctoral student Heather Holmes (now an associate professor of chemical engineering). Holmes installed a particulate matter sensor on a train but for only a short period of time.

When Mitchell arrived at the U as a postdoctoral scholar in 2013 he discussed reviving Holmes' project with faculty advisors Jim Ehleringer, distinguished professor of biology, and John Lin, professor of atmospheric sciences and a co-author of the current study. With support from UTA, Mitchell ran a preliminary study in 2014.

They first test placed air inlet tubes out the window of an unoccupied driver's cab. "I noticed that there was a small CO2 bump every time the TRAX train stopped at a train station," Mitchell says. "This confused me initially, but I realized that the inlet tubes sticking out of the driver window were actually picking up human respiration from people standing at the train platform waiting to board the train!"

The test was a success, and Mitchell partnered with professor John Horel's research group to launch a full-fledged research effort to monitor air quality and greenhouse gases--this time with the sensors on the roof of the train so they aren't affected by people waiting on the train platforms.

Now the program has expanded to additional TRAX lines and ongoing state funding supports the air quality monitoring while additional funding from the National Oceanic and Atmospheric Administration supported this study on greenhouse gas emissions.

Top-down emissions measurement

The study evaluates the TRAX air sensors as a top-down measurement of greenhouse gas emissions. "Top-down" analysis means measuring the atmospheric concentration, and then figuring out where the emissions come from. Another approach, "bottom-up" analysis, inventories all the possible emissions sources and adds them together to estimate the total.

"Top-down measurements allow us to evaluate if the bottom-up emission inventories are accurate," says Derek Mallia, lead author of the study and research assistant professor of atmospheric sciences. "If an emission inventory is off by a little bit or is missing an emissions source, the top-down approach gives us a way to figure that out."

NASA satellites can also be used to estimate top-down emission estimates for cities around the world, an effort Lin and his group are also pursuing. "These satellite measurements are useful for assessing whole cities and for cities that lack ground observations," Lin says, "but the TRAX-based sensors allow for more granularity in emissions throughout the city and can complement the space-based observations."

Top-down measurements of this type over a large area can focus in on particular elements of a city's emissions inventory to identify ways that the inventory needs to change.

"A really simple example of this would be looking at on-road emissions," Mallia says. The researchers found underestimates of on-road emissions by bottom-up inventories, which if observed by only a stationary sensor near a single main road would suggest only potential underestimations for that particular road. But if on-road emissions are being underestimated consistently over an entire city, Mallia says, "fundamentally, this tells us that we are not accounting for something about on-road emissions, in general. This could be really important to understand as more and more people start driving electric vehicles that have zero tailpipe emissions."

As cities work to reduce environmental inequalities, mobile air monitoring can also help monitor if some urban areas' air is improving faster than others, Mitchell adds.

A model for cities to follow

"The TRAX-based measurements, combined with the network of stationary sites, means that Salt Lake City is one of the best-instrumented cities in the world in terms of pollution observations," Lin says.

To the researchers' knowledge, air quality sensors have been installed on public transport platforms in only a handful of cities in Europe. But the same approach could be used in any city with similar light rail systems--Portland, Oregon and Denver, for example. In cities with rail systems that run partially or entirely underground, sensors could be mounted on electric buses.

The cost savings of such an approach is staggering. One research-grade mobile sensor costing $40,000, the authors find, can cover the same area as around 30 stationary sensors costing upwards of $1.2 million.

"This excludes the manpower needed to maintain a 30-station network, which would be immense," Mitchell says. "Long story short--based on our preliminary analysis, semi-continuous mobile measurements on public transit vehicles are a very cost-effective strategy for monitoring emissions in cities."

Credit: 
University of Utah

Will it kombucha? (video)

image: Kombucha is a bubbly, fermented tea that has gained popularity in the health and wellness scene over the last decade -- but what is it exactly? This week, the Reactions team breaks down kombucha's chemistry and investigates which ordinary beverages they can turn into kombucha: https://youtu.be/YxARRckS9dA.

Image: 
The American Chemical Society

WASHINGTON, Dec. 17, 2020 -- Kombucha is a bubbly, fermented tea that has gained popularity in the health and wellness scene over the last decade -- but what is it exactly? This week, the Reactions team breaks down kombucha's chemistry and investigates which ordinary beverages they can turn into kombucha: https://youtu.be/YxARRckS9dA.

Credit: 
American Chemical Society

UBCO research takes the chill off icy build-up on planes and wind turbines

image: UBCO researcher Mohammad Zarifi has made significant improvements to the real-time sensors that monitor frost and ice build-up on airplanes and turbines.

Image: 
UBCO

New UBC Okanagan research is changing the way aircraft and wind turbine operators are addressing the risks related to ice build-up.

In a follow-up study from one released previously this year, Assistant Professor Mohammad Zarifi and his team at UBCO's Okanagan MicroElectronics and Gigahertz Applications (OMEGA) Lab, have broadened the scope and functionality of their ice sensors.

"We received a great deal of interest from the aviation and renewable energy industries stemming from our initial findings which pushed us to expand the boundaries of the sensor's responsiveness and accuracy," explains Zarifi.

Ice build-up on aircraft and wind turbines can impact the safety and efficiency of their systems, he notes.

In this latest research, the researchers focused on improving the real-time response of the sensors to determining frost and ice build-up. The sensors can identify in real-time these accumulations while calculating the rate of melting. This is crucial data for aviation, for keeping flights on time, and renewable energy applications, says Zarifi.

"Power generation output of wind turbines diminishes as a result of ice accumulations," he adds. "So, the industry sees great promise in sensing and de-icing solutions that can mitigate those reductions in efficiency."

Zarifi says the patented sensor, which includes a protective layer, is now being tested by the aviation industry through a rigorous approval process. This needs to be done before it can become a permanent fixture on aircraft. He notes that recently announced funding from the Department of National Defense will enable his team to continue to improve the sensor's capabilities.

Zarifi is also collaborating with a number of wind turbine companies to adapt the sensors into wind farms. The wind farm application is a slightly more straightforward proposition, he says, because the sensors can be mounted at the same altitude of the blades without having to be mounted to the blades--this removes certain calculation variables that are related to motion.

In the midst of these breakthroughs, the researchers have uncovered another first when it comes to ice sensing technology. Their latest innovation can sense salty ice, which freezes at colder temperatures. Interest in understanding and monitoring saltwater ice formation is increasing due to issues caused by saltwater ice on oil rigs and marine infrastructure. Zarifi and his team at OMEGA Lab are working towards the introduction of microwave/radar-based technology to address this challenge.

By incorporating an antenna into the sensor, the results can be shared in real-time with the operator in order to address the build-up.

Zarifi says his team is as excited as the industry partners to see how their microwave and antenna, which have proven to be durable and robust, can be modified for various applications including ice and moisture sensing.

Credit: 
University of British Columbia Okanagan campus

Research strongly suggests COVID-19 virus enters the brain

image: The S1 protein likely causes the brain to release inflammatory products causing a storm in the brain, researchers said.

Image: 
Alice Gray

More and more evidence is coming out that people with COVID-19 are suffering from cognitive effects, such as brain fog and fatigue.

And researchers are discovering why. The SARS-CoV-2 virus, like many viruses before it, is bad news for the brain. In a study published Dec.16 in Nature Neuroscience, researchers found that the spike protein, often depicted as the red arms of the virus, can cross the blood-brain barrier in mice.

This strongly suggests that SARS-CoV-2, the cause of COVID-19, can enter the brain.

The spike protein, often called the S1 protein, dictates which cells the virus can enter. Usually, the virus does the same thing as its binding protein, said lead author William A. Banks, a professor of medicine at the University of Washington School of Medicine and a Puget Sound Veterans Affairs Healthcare System physician and researcher. Banks said binding proteins like S1 usually by themselves cause damage as they detach from the virus and cause inflammation.

"The S1 protein likely causes the brain to release cytokines and inflammatory products," he said.

In science circles, the intense inflammation caused by the COVID-19 infection is called a cytokine storm. The immune system, upon seeing the virus and its proteins, overreacts in its attempt to kill the invading virus. The infected person is left with brain fog, fatigue and other cognitive issues.

Banks and his team saw this reaction with the HIV virus and wanted to see if the same was happening with SARS CoV-2.

Banks said the S1 protein in SARS-CoV2 and the gp 120 protein in HIV-1 function similarly. They are glycoproteins - proteins that have a lot of sugars on them, hallmarks of proteins that bind to other receptors. Both these proteins function as the arms and hand for their viruses by grabbing onto other receptors. Both cross the blood-brain barrier and S1, like gp120, is likely toxic to brain tissues.

"It was like déjà vu," said Banks, who has done extensive work on HIV-1, gp120, and the blood-brain barrier.

The Banks' lab studies the blood-brain barrier in Alzheimer's, obesity, diabetes, and HIV. But they put their work on hold and all 15 people in the lab started their experiments on the S1 protein in April. They enlisted long-time collaborator Jacob Raber, a professor in the departments of Behavioral Neuroscience, Neurology, and Radiation Medicine, and his teams at Oregon Health & Science University.

The study could explain many of the complications from COVID-19.

"We know that when you have the COVID infection you have trouble breathing and that's because there's infection in your lung, but an additional explanation is that the virus enters the respiratory centers of the brain and causes problems there as well," said Banks.

Raber said in their experiments transport of S1 was faster in the olfactory bulb and kidney of males than females. This observation might relate to the increased susceptibility of men to more severe COVID-19 outcomes.

As for people taking the virus lightly, Banks has a message:

"You do not want to mess with this virus," he said. "Many of the effects that the COVID virus has could be accentuated or perpetuated or even caused by virus getting in the brain and those effects could last for a very long time."

Credit: 
University of Washington School of Medicine/UW Medicine